Alon Ben Noon
CEO, NeuroSense Therapeutics
Alon Ben-Noon is co-founder and CEO of NeuroSense Therapeutics, a drug development company focusing on the treatment of ALS and other neurodegenerative diseases.
Show Notes
01:13 Tell us about your career journey and meeting Shay Rishoni
06:25 Tell us about ALS and why it has become a relatively well-known orphan indication
09:30 Tell us about PrimceC
12:40 Could you talk about your financing journey
16:13 Did the crowdfunding process affect your public offering in some sort of way?
18:54 Is it true that zebrafish have over 70% genetic similarity to humans? How is that even possible?
21:00 Could you expand on the leadership team at NeuroSense?
23:10 How has your personal life changed since the company was floated to NASDAQ?
25:00 You have a very unique organizational culture in NeuroSense Therapeutics and you're growing. How do you intend to keep some of that culture while you grow?
27:30 What’s next forNeuroSense? What are the next milestones and pipeline products?
30:15 How long do you expect you are away from the market with the PrimeC?
31:05 Have you put any thoughts to having a companion diagnostic?
32:25 What are your thoughts about the Israeli ecosystem?
34:25 If you could go back to your 16-year-old self and tell yourself something, what do you think it would be?
35:40 Are there any people in your journey that were meaningful to you personally and to NeuroSense Therapeutics
Interview Transcription (mild edits)
Coming soon
Links
(More) Amazing people to learn from
Daniella Gilboa is the CEO of AIVF, a company is out to transform the fertility and IVF treatment journey.
Cecile Blilious is the Head of Impact and Sustainability at Pitango Venture Capital
Nahum Ferera is CEO of EyeYon Medical, a company he co-founded in 2011, that is developing therapies for a range of corneal diseases.
Dedi Gilad is the CEO of TytoCare, the healthcare industry's first all-in-one modular telehealth device and AI-powered platform for on-demand remote medical exams and visits.
Yoav Fisher is Head of Technological Innovation and Digital Health- HealthIL. HealthIL is part of the Israel Innovation Institute, a not for profit organization bringing innovative technology and knowledge into real-world settings
Danny Farin is CEO of Perflow Medical, which develops and commercializes devices for stroke. His previous venture, EON Surgical, was sold to Teleflex.